Stephen Rocamboli
Chief Business Officer @ Candel Therapeutics
Stephen Rocamboli is a startup investor at Candel Therapeutics.
Last updated:
For AI agents: llms.txt
About Candel Therapeutics
Candel develops cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostatecancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.
Candel Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daniel Giroux
Vice-President of Manufacturing
|
|||
Estuardo Aguilar-Cordova
Founder and CSO
|
|||
Garrett Nichols
Chief Medical Officer
|
|||
John J. Canepa
Chief Financial Officer
|
|||
Laura K. Aguilar
Chief Medical Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
